LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 91.27 | 84.90 | 1382 | 7420 | 0.1863 | 0.5412 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 91.27 | 84.90 | 11152 | 7420 | 1.5029 | 1.1304 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 92.98 | 84.90 | 5512 | 7257 | 0.7595 | 0.9161 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 92.98 | 84.90 | 11087 | 7257 | 1.5276 | 1.1365 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 92.98 | 84.90 | 1465 | 7257 | 0.2019 | 0.5586 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 92.98 | 84.90 | 11418 | 7257 | 1.5732 | 1.1463 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 94.68 | 84.90 | 4561 | 7000 | 0.6515 | 0.8698 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 94.68 | 84.90 | 11298 | 7000 | 1.6139 | 1.1562 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 94.68 | 84.90 | 1409 | 7000 | 0.2013 | 0.5547 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 94.68 | 84.90 | 11727 | 7000 | 1.6752 | 1.1688 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.66 | 84.90 | 457 | 285 | 1.5994 | 1.6152 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.66 | 84.90 | 3 | 285 | 0.0105 | -0.8518 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 2.66 | 84.90 | 743 | 285 | 2.6003 | 2.4519 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.36 | 84.90 | 533 | 322 | 1.6523 | 1.5959 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 4.36 | 84.90 | 873 | 322 | 2.7064 | 2.3539 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.06 | 84.90 | 611 | 365 | 1.6719 | 1.5528 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.06 | 84.90 | 6 | 365 | 0.0164 | -0.7158 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 6.06 | 84.90 | 987 | 365 | 2.7008 | 2.2057 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.77 | 84.90 | 671 | 411 | 1.6317 | 1.4800 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 7.77 | 84.90 | 6 | 411 | 0.0146 | -0.6878 | MN20160318_Q02 | I21 |